The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation

AIM OF THE STUDY: Treatment toxicity may decrease the treatment effectiveness due to the need to reduce the dose or increase the interval between cycles. The aim of this study was to distinguish the risk factors for treatment side effects in breast cancer patients and to assess the impact of BRCA1/2...

Descripción completa

Detalles Bibliográficos
Autores principales: Huszno, Joanna, Budryk, Magdalena, Kołosza, Zofia, Nowara, Elżbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507882/
https://www.ncbi.nlm.nih.gov/pubmed/26199574
http://dx.doi.org/10.5114/wo.2015.50014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507882/
https://www.ncbi.nlm.nih.gov/pubmed/26199574
http://dx.doi.org/10.5114/wo.2015.50014

Ejemplares similares